Hemp, FDA and the Regulatory Status of CBD - Stuart Tomc
Update: 2018-09-13
Description
Mr. Tomc is the Vice President of Human Nutrition at CV Sciences. He is a recognized authority on dietary supplements, with twenty years of experience in the nutritional health industry. Formerly the Vice President of North American Herb and Spice, where he served for 10 years, in addition to his service as Global Educator for omega-3 market leader, Nordic Naturals, Mr. Tomc is known for his extensive print interviews and contributions to noted books on integrative medicine, as well as his 4,000 radio appearances. A renowned educator, Mr. Tomc recognizes CBD and its multiple mechanisms of action to support human health, and envisions a new category of dietary supplements derived from agricultural hemp.
Topics:
2:35 - From Omega 3 to CBD
4:30 - Eicosanoids and endocannabiods
8:15 - Who is CV Sciences?
12:00 - Regulatory status of CBD and hemp
17:20 - Who is the US Hemp Roundtable
21:14 - Over-the-Counter CBD products
23:35 - Marijuana-dervied CBD
26:35 - Great efficacy w/ terpenes?
29:30 - Isolated CBD v. whole-spectrum CBD
40:00 - Sativex v. Dronabinol
41:00 - Toxicology & safety of hemp extracts
44:00 - GRAS designation
50:00 - NOAEL (No-observed-adverse-effect level)
54:00 - Rescheduling of CBD
60:00 - Regulatory status of CBD post-Epidiolex
Studies mentioned in this podcast:
Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol
An Assessment of the Genotoxicity and Subchronic Toxicity of a Supercritical Fluid Extract of the Aerial Parts of Hemp
Topics:
2:35 - From Omega 3 to CBD
4:30 - Eicosanoids and endocannabiods
8:15 - Who is CV Sciences?
12:00 - Regulatory status of CBD and hemp
17:20 - Who is the US Hemp Roundtable
21:14 - Over-the-Counter CBD products
23:35 - Marijuana-dervied CBD
26:35 - Great efficacy w/ terpenes?
29:30 - Isolated CBD v. whole-spectrum CBD
40:00 - Sativex v. Dronabinol
41:00 - Toxicology & safety of hemp extracts
44:00 - GRAS designation
50:00 - NOAEL (No-observed-adverse-effect level)
54:00 - Rescheduling of CBD
60:00 - Regulatory status of CBD post-Epidiolex
Studies mentioned in this podcast:
Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Overcoming the Bell-Shaped Dose-Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol
An Assessment of the Genotoxicity and Subchronic Toxicity of a Supercritical Fluid Extract of the Aerial Parts of Hemp
Comments
In Channel













